Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Bibliografski detalji
Glavni autori: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Format: Conference item
Izdano: 2009
_version_ 1826289669226102784
author Anthony, D
Sibson, N
Losey, P
Piani, D
Leppert, D
author_facet Anthony, D
Sibson, N
Losey, P
Piani, D
Leppert, D
author_sort Anthony, D
collection OXFORD
description
first_indexed 2024-03-07T02:32:24Z
format Conference item
id oxford-uuid:a7b0f5ab-a14c-4f3e-a44c-5aa476f2f04a
institution University of Oxford
last_indexed 2024-03-07T02:32:24Z
publishDate 2009
record_format dspace
spelling oxford-uuid:a7b0f5ab-a14c-4f3e-a44c-5aa476f2f04a2022-03-27T02:56:13ZOral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosisConference itemhttp://purl.org/coar/resource_type/c_5794uuid:a7b0f5ab-a14c-4f3e-a44c-5aa476f2f04aSymplectic Elements at Oxford2009Anthony, DSibson, NLosey, PPiani, DLeppert, D
spellingShingle Anthony, D
Sibson, N
Losey, P
Piani, D
Leppert, D
Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title_full Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title_fullStr Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title_full_unstemmed Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title_short Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
title_sort oral fingolimod fty720 therapy reduces blood brain barrier breakdown microglial activation and leukocyte recruitment in a focal dth model of multiple sclerosis
work_keys_str_mv AT anthonyd oralfingolimodfty720therapyreducesbloodbrainbarrierbreakdownmicroglialactivationandleukocyterecruitmentinafocaldthmodelofmultiplesclerosis
AT sibsonn oralfingolimodfty720therapyreducesbloodbrainbarrierbreakdownmicroglialactivationandleukocyterecruitmentinafocaldthmodelofmultiplesclerosis
AT loseyp oralfingolimodfty720therapyreducesbloodbrainbarrierbreakdownmicroglialactivationandleukocyterecruitmentinafocaldthmodelofmultiplesclerosis
AT pianid oralfingolimodfty720therapyreducesbloodbrainbarrierbreakdownmicroglialactivationandleukocyterecruitmentinafocaldthmodelofmultiplesclerosis
AT leppertd oralfingolimodfty720therapyreducesbloodbrainbarrierbreakdownmicroglialactivationandleukocyterecruitmentinafocaldthmodelofmultiplesclerosis